Nuvisan, Innovation Campus Berlin, Berlin, Germany

University of North Carolina (UNC), Chapel Hill, USA

University of Torino, Torino, Italy

University of Pavia, Pavia, Italy

Duke University Medical Center, North Carolina, USA

Christie NHS Foundation Trust, University of Manchester, Manchester, UK

NYU Langone Health, New York, USA

University of Luxembourg

Cold Spring Harbor Laboratory, New York, USA

Ernest Nadal (Catalan Institute of Oncology (ICO); Bellvitge Biomedical Research Institute (IDIBELL); L'Hospitalet, Barcelona, Spain)

National Cancer Institute RAS Initiative (Frederick National Laboratory for Cancer Research, Frederick, MD) & University of California, San Francisco (UCSF), Helen Diller Family Comprehensive Cancer Center, USA.

University of Liverpool, Liverpool, UK

Mirati Therapeutics, San Diego, USA

The Francis Crick Institute, London, UK

Barts Cancer Institute, London, UK

Howard Hughes Medical Institute, Maryland, USA & University of California San Francisco (UCSF), San Francisco, USA & University of California (UC Berkeley), Berkeley, USA.

Hospital Universitario 12 de Octubre, Madrid, Spain

Centro de Investigaciones Oncológicas (CNIO), Madrid, Spain

Revolution Medicines, Redwood City, USA

Beatson Institute for Cancer Research, Glasgow. UK

University College London (UCL), London, UK

Bridge Bio, Palo Alto, USA

IBBTEC, University of Cantabria, Santander, Spain

Hospital Universitario Ramón y Cajal & Universidad de Alcalá

Amgen, Thousand Oaks, California, USA

Netherlands Cancer Institute, Amsterdam, Netherlands

National Cancer Institute (NCI), Frederick, USA

Novartis Institutes for Biomedical Research, Boston, USA

CIMA, University of Navarra, Pamplona, Spain

The Institute of Cancer Research, London, UK

Systems Biology Ireland, University College Dublin, Dublin, Ireland

Centro de investigación del Cáncer (CIC), Salamanca, Spain

D. E. Shaw Research, New York, USA